Multimodality treatment strategies have changed prognosis of peritoneal metastases

doi:10.4251/wjgo.v8.i1.67

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8448)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-10) series, Tables (1-2) series.

Item

Count

PDF

538

WORD

379

HTML

4691

Figures (1-10)

229

Tables (1-2)

217

Sum=6054

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1005

Download

1389

Sum=2394

Jan 15, 2016 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Jan 15, 2016; 8(1): 67-82
Published online Jan 15, 2016. doi: 10.4251/wjgo.v8.i1.67

Full Size Figure Download Figure

Figure 8 Kaplan-Meier survival curve of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment, for colorectal peritoneal carcinomatosis, stratified by completeness of cytoreduction score[33] (with permission). Kaplan-Meier survival curve of CRS-HIPEC treatment, for Colorectal PM, stratified by CCRS[33]: Available from: URL: http://click.info.copyright.com/?qs=2b7046b10dd0c5471bbbb8bac0096e00e895f442c0326423b795894c1892230b84270e7e00c4e014. CCRS: Completeness of cytoreduction score; CRS-HIPEC: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy; PM: Peritoneal metastases.

Citation: Lungoci C, Mironiuc AI, Muntean V, Oniu T, Leebmann H, Mayr M, Piso P. Multimodality treatment strategies have changed prognosis of peritoneal metastases. World J Gastrointest Oncol 2016; 8(1): 67-82
URL: https://www.wjgnet.com/1948-5204/full/v8/i1/67.htm
DOI: https://dx.doi.org/10.4251/wjgo.v8.i1.67